Literature DB >> 21153897

Hyperkalaemia associated with hydroxyurea in a patient with polycythaemia vera.

Srecko Marusic, Nives Gojo-Tomic, Vesna Bacic-Vrca, Velimir Bozikov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21153897     DOI： 10.1007/s00228-010-0962-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

Review 1.  Hydroxyurea and hydroxamic acid derivatives as antitumor drugs.

Authors:  Nina Saban; Maro Bujak
Journal:  Cancer Chemother Pharmacol       Date:  2009-04-07       Impact factor: 3.333

2.  Pseudohyperkalemia in patients with increased cellular components of blood.

Authors:  Nikolaos Sevastos; George Theodossiades; Savvas P Savvas; Konstantinos Tsilidis; Stamatis Efstathiou; Athanasios J Archimandritis
Journal:  Am J Med Sci       Date:  2006-01       Impact factor: 2.378

Review 3.  Drug-induced hyperkalemia: old culprits and new offenders.

Authors:  M A Perazella
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 5.  Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.

Authors:  David Dingli; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 6.  Hyperkalemia.

Authors:  Joyce C Hollander-Rodriguez; James F Calvert
Journal:  Am Fam Physician       Date:  2006-01-15       Impact factor: 3.292
  6 in total
  1 in total

Review 1.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.